Amlexanox

氨来呫诺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmlexanox
Drug Alias Name氨米占司Amoxanox氨来咕诺氨来占诺Apthera +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists3',5'-cyclic phosphodiesterase inhibitors
TargetsHistamine H1 receptor3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsUlcerObesityDiabetes Mellitus, Type 2 +[8] 
Global Approved IndicationsUlcerRhinitis, AllergicAsthma +[4] 
Approved Indications in ChinaUlcer
Original Approved Country/TerritoryJapan
Original Approved Date1987/01/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co LtdSenju Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Keyuan Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of MichiganAccess Pharmaceuticals IncUluru Inc
Active IndicationsUlcerRhinitis, AllergicAsthma
Inactive IndicationsObesityDiabetes Mellitus, Type 2Stomatitis, Aphthous +[5] 

Other Information

ATC CodeA01AD07R03DX01
Related LinksWikipediaDrugBankKEGG